Back to Search
HOWARD GERSTEIN, MD
MD
Family Medicine Physician
NPI: 1346298999Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MDO4O383(PA)
Research & Publications (20)
Is it possible to reduce cardiovascular risk with glucose-lowering approaches?
PMID 19444260·Nat Rev Endocrinol·2009
6-review
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
PMID 18695086·Arch Intern Med·2008
2-rct
Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach.
PMID 17259525·Diabetes Care·2007
8-other
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
PMID 17601626·Diabetes Res Clin Pract·2007
1-meta
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
PMID 17599423·Am J Cardiol·2007
2-rct
Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
PMID 17848926·Nat Clin Pract Endocrinol Metab·2007
8-other
Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation?
PMID 15752926·Endocrinol Metab Clin North Am·2005
6-review
Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors. The example of albuminuria and the risk of cardiovascular disease in diabetes.
PMID 12227118·Endocrinol Metab Clin North Am·2002
6-review
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial.
PMID 11850097·Diabetes Res Clin Pract·2002
3-trial
The plasma glucose level--a continuous risk factor for vascular disease in both diabetic and non-diabetic people.
PMID 11900390·Adv Exp Med Biol·2001
8-other
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
PMID 11466120·JAMA·2001
4-observational
Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.
PMID 19622625·J Clin Endocrinol Metab·2009
8-other
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.
PMID 19171735·Diabetes Care·2009
2-rct
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
PMID 19196892·Diabetes Care·2009
8-other
Dysglycemia and cardiovascular risk in the general population.
PMID 19221229·Circulation·2009
6-review
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
PMID 19332208·Am Heart J·2009
4-observational
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
PMID 19477351·J Am Coll Cardiol·2009
2-rct
Intensive glucose control and macrovascular outcomes in type 2 diabetes.
PMID 19655124·Diabetologia·2009
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 734 N FRANKLIN ST
LANCASTER, PA 17602 - Phone
- (717) 295-2323
Quick Facts
- NPI
- 1346298999
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile